Tagged Articles

transvaginal mesh 230 articles

Bard settles transvaginal mesh lawsuits

2012-TVM-serious-complications

C.R. Bard has agreed to settle nearly 100 lawsuits related to its transvaginal mesh (TVM) devices that were pending in U.S. District Court in West Virginia. Thousands of TVM cases are consolidated under U.S. District Judge Joseph R. Goodwin. In addition to Bard, cases are pending against other medical device manufacturers including Johnson & Johnson and Boston Scientific. In August 2013, Bard was hit with a $2.2 million jury verdict in the first transvaginal mesh lawsuit to go to trial in the consolidated multidistrict litigation (MDL). A jury found that the company’s Avaulta Plus Posterior BioSynthetic Support System TVM, used ... Read More

Louisiana Woman Files Lawsuit alleging Physiomesh Injuries

physiomesh

The Louisiana Record reports that Laura Lutz of Port Sulphur, Louisiana, has filed a lawsuit against Johnson & Johnson and Ethicon Inc., alleging negligence and other counts regarding her injuries allegedly linked to Physiomesh Flexible Composite Hernia Mesh device. Physiomesh is a flexible mesh made of polypropylene designed to reinforce the abdominal wall, supposedly keeping additional hernias from forming. Polypropylene is a thermoplastic polymer used in a wide variety of ways, including packaging and labeling, ropes, fabric for thermal underwear, reusable containers, laboratory equipment, and transvaginal mesh (TVM), which also has been linked to complications. TVM is a knitted polypropylene monofilament used to ... Read More

J&J faces wave of lawsuits over pharmaceuticals, medical devices, health care products

johnsonandjohnson

Johnson & Johnson and its subsidiaries are being hit by a growing wave of lawsuits alleging the world’s largest health care company’s pharmaceuticals, medical devices and health care products cause serious injuries and deaths. More than 100,000 people, including 18,500 men who claim they grew disfiguring female-like breasts after taking the antipsychotic Risperdal as adolescents, sued J&J in 2016 – an increase of about 28,3000 over the previous year. J&J disclosed that its litigation expenses to fight these claims jumped 480 percent in 2016 to a whopping $817 million. Plaintiffs suing J&J and its subsidiary Janssen Pharmaceuticals over Risperdal side ... Read More

Bellwether verdict against J&J pelvic mesh upheld by NJ Supreme Court

TVM woman

Mass Tort Nexus reports that the New Jersey Supreme Court has upheld an $11.11 million verdict from a February 2013 bellwether trial against Johnson & Johnson unit Ethicon, Inc. over its Gynecare Prolift mesh product used to treat pelvic organ prolapse and adverse effects related to the product. The Supreme Court refused to hear an appeal by the company, which had previously had post-trial motions denied by New Jersey Superior Court Judge Carol E. Higbee. Also in March this year a three-judge appellate panel of the state appeals court heard the defendant’s oral arguments challenging Judge Higbee’s decision to uphold ... Read More

Strengthen your pelvic floor with new app that turns kegel exercise into a game

2012-TVM-serious-complications

In a recent video, the host of Refinery 29’s series Femme Ed, Laura Willcox, learned how kegel exercises can strengthen a woman’s pelvic floor and why this is so important for many women. “Why should a woman concern herself with strengthening her pelvic floor or doing kegels? What’s the upside here?” Willcox asked pelvic floor expert Jill Hoefs. “A lot of women do it because either they’re leaking [urine] on themselves or because they feel like their organs are going to fall out of their body,” Hoefs replied to a shuddering Willcox. Stress urinary incontinence and pelvic organ prolapse, the ... Read More

Medication to treat stress urinary incontinence being tested as safer alternative to transvaginal mesh

2012-TVM-serious-complications

There might be a new non-invasive option for treating stress urinary incontinence (SUI). Up to 35 percent of adult women are affected by this common disorder, which is when coughing, laughing, sneezing, lifting or exercising can trigger unintentional urine leakage. A new oral treatment, a once-a-day pill, is being tested by urologists at Beaumont Hospital in Royal Oak, Mich. The medicine, enobosarm, rebuilds muscle mass and has been studied already for its usefulness for cancer patients. It is a selective androgen receptor modulator. “This isn’t a situation that you have to live with. Know that it isn’t. Get help for ... Read More

More than 100 additional Suits Resolved in Transvaginal Mesh MDL

2012-TVM-serious-complications

Law360 reports that Endo International plc unit American Medical Systems Inc. has settled approximately 135 more suits in the multidistrict litigation (MDL) in West Virginia against the seven manufacturers of transvaginal mesh implants. The seven MDLs have been consolidated into one giant litigation totaling around 70,000 pending cases. Last year AMS settled about 360 cases in April, another 108 in May and another 100 by July. The previous year according to Law360 Endo paid $830 million to settle 20,000 suits. “In a joint motion to dismiss, AMS said it had compromised and settled claims in roughly 135 suits filed by ... Read More

States prosecute Johnson & Johnson alleging ‘deceptive practices’ related to transvaginal mesh

2012-TVM-serious-complications

Besides the 35,000 personal injury lawsuits that Johnson and Johnson faces related to its transvaginal mesh (TVM), the company is also facing suits by both the states of Washington and California. According to Law360, the states’ attorneys general filed complaints against the company and its subsidiary Ethicon Inc. alleging false advertising and deceptive marketing related to the devices. The complaints claim J&J knowingly concealed the risks associated with its TVM product and misrepresented the severity and frequency of common complications. The complaints also claim violations of the states’ unfair competition and consumer protection laws. Law360 reported that “Both states are seeking injunctive relief and ... Read More

People are asking how banned transvaginal mesh device TFS was ever allowed on the market

2012-TVM-serious-complications

This week the Australian Broadcasting Corporation (ABC) on Lateline interviewed grandmother Barb Jobson about the devastating consequences of the Australian-made transvaginal mesh device that was banned just 13 months after she had her operation. “There was no indication that there was going to be any problems. It was God’s answer to women,” Barb told ABC. She hadn’t been warned about any potential complications and the device had been advertised as proven safe and effective in spite of the fact that two years earlier medical experts had published a paper raising concerns about the product, known as TFS. According to MSN the ... Read More

Women’s Health Medical Devices Market Research Report just published

2012-TVM-serious-complications

A Women’s Health Medical Devices Market Research Report has just been published by Market Reports World offering insight into growth markets and unmet needs in the women’s health industry, analysis of trends and of current and future competition in the U.S. market, and looking into what has hindered the adoption of newer technologies, among other things. It specifically offers physicians’ perspectives, with perceptive quotes from leading gynecologists, urogynecologists, interventional radiologists, and general surgeons from around the world. The women’s health medical device market includes technologies such as global endometrial devices, endometrial resection devices, uterine fibroid embolization agents, female sterilization devices, ... Read More